 Glupigon-like peptid-1, GLP-1, is a hormone that stimulates insulin secretion and slows gastric emptying, making it an effective treatment for type 2 diabetes. GLP-1 also has anti-inflammatory effects in chronic inflammatory diseases such as type 1 and 2 diabetes, atherosclerosis, neurodegenerative disorders, non-alcoholic steetohibatis, diabetic nephropathy, asthma, and psoriasis. GLP-1-based therapies have been developed to treat these diseases, and their molecular mechanisms of anti-inflammatory action are being studied. This article was authored by young son Lee, and he's sick, John.